Drug-resistant tuberculosis.
Multiply resistant tuberculosis is on the rise throughout the world. It poses the risk that an increasing percentage of patients will have disease that cannot be cured in economically limited nations and, thus, resistant tubercle bacilli will be spread in an exponential manner. For such patients in the United States, aggressive chemotherapy, coupled with surgery in cases of localized disease, is the best hope for cure.
Iseman
M D
MD
Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado.
Madsen
L A
LA
D000328:Adult; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D011013:Pneumonectomy; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents